66 results
Search Results
2. Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas
3. Importance of beta cell mass for glycaemic control in people with type 1 diabetes
4. In vivo imaging of vesicular monoamine transporter 2 in pancreas using an 18F epoxide derivative of tetrabenazine
5. The second-generation antipsychotic drug aripiprazole modulates the serotonergic system in pancreatic islets and induces beta cell dysfunction in female mice
6. In Vivo ZIMIR Imaging of Mouse Pancreatic Islet Cells Shows Oscillatory Insulin Secretion.
7. Associations of birthweight and history of childhood obesity with beta cell mass in Japanese adults
8. Beta cells in type 1 diabetes: mass and function; sleeping or dead?
9. Futility of attempts to detect and quantify beta cells by PET imaging in the pancreas: why it is time to abandon the approach
10. Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging
11. Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats
12. The development of a GPR44 targeting radioligand [11C]AZ12204657 for in vivo assessment of beta cell mass
13. Species differences in pancreatic binding of DO3A-VS-Cys40-Exendin4
14. The p21-activated kinase (PAK1) is involved in diet-induced beta cell mass expansion and survival in mice and human islets.
15. Development of a peptide-functionalized imaging nanoprobe for the targeting of (FXYD2)γa as a highly specific biomarker of pancreatic beta cells.
16. Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled Exendin
17. Islet biology, the CDKN2A/B locus and type 2 diabetes risk
18. GPR44 is a pancreatic protein restricted to the human beta cell
19. Cross-sectional and Test-Retest Characterization of PET with [18F]FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes
20. Ileal Interposition and Viability of Pancreatic Islets Transplanted into Intramuscular Site of Diabetic Rats.
21. Inside the pancreas: progress and challenges of human beta cell mass quantification.
22. Reporter islets in the eye reveal the plasticity of the endocrine pancreas.
23. Prolactin-stimulated survivin induction is required for beta cell mass expansion during pregnancy in mice
24. A Standardized Method for In Vivo Mouse Pancreas Imaging and Semiquantitative β Cell Mass Measurement by Dual Isotope SPECT
25. Targeting GLP-1 receptors for repeated magnetic resonance imaging differentiates graded losses of pancreatic beta cells in mice
26. A euglycaemic/non-diabetic perinatal environment does not alleviate early beta cell maldevelopment and type 2 diabetes risk in the GK/Par rat model.
27. Beta cell adaptation in pregnancy: a major difference between humans and rodents?
28. Getting beta all the time: discovery of reliable markers of beta cell mass.
29. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality.
30. Evidence for the homeostatic regulation of induced beta cell mass expansion.
31. The regulation of pre- and post-maturational plasticity of mammalian islet cell mass
32. Non-invasive quantification of the beta cell mass by SPECT with 111In-labelled exendin
33. Nupr1 deletion protects against glucose intolerance by increasing beta cell mass
34. Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice
35. Species-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models
36. Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice
37. Ciliary neurotrophic factor (CNTF) protects non-obese Swiss mice against type 2 diabetes by increasing beta cell mass and reducing insulin clearance
38. Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis
39. Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans
40. Chronic treatment with a glucokinase activator delays the onset of hyperglycaemia and preserves beta cell mass in the Zucker diabetic fatty rat
41. Imaging the islet graft by positron emission tomography
42. Decreased defluorination using the novel beta-cell imaging agent [18F]FE-DTBZ-d4 in pigs examined by PET
43. Towards PET Imaging of Intact Pancreatic Beta Cell Mass: A Transgenic Strategy
44. Hypercholesterolaemia, signs of islet microangiopathy and altered angiogenesis precede onset of type 2 diabetes in the Goto–Kakizaki (GK) rat
45. Pancreatic alpha cell mass in European subjects with type 2 diabetes
46. Epidermal growth factor (EGF)-receptor signalling is needed for murine beta cell mass expansion in response to high-fat diet and pregnancy but not after pancreatic duct ligation
47. The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes
48. Bioluminescence Imaging in Mouse Models Quantifies β Cell Mass in the Pancreas and After Islet Transplantation
49. Relationship between fractional pancreatic beta cell area and fasting plasma glucose concentration in monkeys
50. Perinatal survivin is essential for the establishment of pancreatic beta cell mass in mice
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.